| Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants MA Livrea, L Tesoriere, AM Pintaudi, A Calabrese, A Maggio, ... | 368 | 1996 |
| The safety and effectiveness of deferiprone in a large‐scale, 3‐year study in Italian patients A Ceci, P Baiardi, M Felisi, MD Cappellini, V Carnelli, V De Sanctis, ... British journal of haematology 118 (1), 330-336, 2002 | 294 | 2002 |
| Deferiprone versus deferoxamine in patients with thalassemia major: a randomized clinical trial A Maggio, G d'Amico, A Morabito, M Capra, C Ciaccio, P Cianciulli, ... Blood Cells, Molecules, and Diseases 28 (2), 196-208, 2002 | 272 | 2002 |
| Multislice multiecho T2* cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overload A Pepe, V Positano, MF Santarelli, F Sorrentino, E Cracolici, D De Marchi, ... Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2006 | 220 | 2006 |
| Hepatocellular carcinoma in the thalassaemia syndromes C Borgna‐Pignatti, G Vergine, T Lombardo, MD Cappellini, P Cianciulli, ... British journal of haematology 124 (1), 114-117, 2004 | 215 | 2004 |
| Rapid and simultaneous typing of hemoglobin S, hemoglobin C, and seven Mediterranean beta-thalassemia mutations by covalent reverse dot-blot analysis: application to prenatal … A Maggio, A Giambona, SP Cai, J Wall, YW Kan, FF Chehab | 204 | 1993 |
| Lack of evidence of permanent engraftment after in utero fetal stem cell transplantation in congenital hemoglobinopathies1 M Westgren, O Ringden, S Eik-Nes, S Ek, M Anvret, AM Brubakk, ... Transplantation 61 (8), 1176-1179, 1996 | 163 | 1996 |
| Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging A Pepe, A Meloni, M Capra, P Cianciulli, L Prossomariti, C Malaventura, ... haematologica 96 (1), 41, 2011 | 161 | 2011 |
| A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference S Samakoglu, L Lisowski, T Budak-Alpdogan, Y Usachenko, S Acuto, ... Nature biotechnology 24 (1), 89-94, 2006 | 161 | 2006 |
| Evaluation of the efficacy of oral deferiprone in β‐thalassemia major by multislice multiecho T2 A Pepe, M Lombardi, V Positano, E Cracolici, M Capra, R Malizia, ... European journal of haematology 76 (3), 183-192, 2006 | 140 | 2006 |
| Standardized T2* map of normal human heart in vivo to correct T2* segmental artefacts V Positano, A Pepe, MF Santarelli, B Scattini, D De Marchi, A Ramazzotti, ... NMR in Biomedicine: An International Journal Devoted to the Development and …, 2007 | 137 | 2007 |
| The significance of the hemoglobin A2 value in screening for hemoglobinopathies A Giambona, C Passarello, D Renda, A Maggio Clinical biochemistry 42 (18), 1786-1796, 2009 | 132 | 2009 |
| Multicenter validation of the magnetic resonance T2* technique for segmental and global quantification of myocardial iron A Ramazzotti, A Pepe, V Positano, G Rossi, D De Marchi, MG Brizi, ... Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2009 | 132 | 2009 |
| The risks of early cordocentesis (12–21 weeks): analysis of 500 procedures F Orlandi, G Damiani, C Jakil, S Lauricella, O Bertolino, A Maggio Prenatal diagnosis 10 (7), 425-428, 1990 | 127 | 1990 |
| Oral supplements of vitamin E improve measures of oxidative stress in plasma and reduce oxidative damage to LDL and erythrocytes in β-thalassemia intermedia patients L Tesoriere, D D'Arpa, D Butera, M Allegra, D Renda, A Maggio, ... Free Radical Research 34 (5), 529-540, 2001 | 113 | 2001 |
| Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel V Di Marco, M Capra, E Angelucci, C Borgna-Pignatti, P Telfer, P Harmatz, ... Blood, The Journal of the American Society of Hematology 116 (16), 2875-2883, 2010 | 112 | 2010 |
| Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society … A Maggio, A Vitrano, M Capra, L Cuccia, F Gagliardotto, A Filosa, ... Blood Cells, Molecules, and Diseases 42 (3), 247-251, 2009 | 112 | 2009 |
| Guideline recommendations for heart complications in thalassemia major T Cogliandro, G Derchi, L Mancuso, MC Mayer, B Pannone, A Pepe, ... Journal of Cardiovascular Medicine 9 (5), 515-525, 2008 | 109 | 2008 |
| Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn's disease in Southern Italy W Fries, MC Renda, MAL Presti, A Raso, A Orlando, L Oliva, MR Giofré, ... Official journal of the American College of Gastroenterology| ACG 100 (12 …, 2005 | 109 | 2005 |
| Oxidative modification of low-density lipoprotein and atherogenetic risk in β-thalassemia MA Livrea, L Tesoriere, A Maggio, D D’arpa, AM Pintaudi, E Pedone Blood, The Journal of the American Society of Hematology 92 (10), 3936-3942, 1998 | 109 | 1998 |
